President Donald Trump is taking a sledgehammer to the pharmaceutical industry’s stranglehold on American wallets. Today, he signed an executive order that promises to slash prescription drug and pharmaceutical prices by an unprecedented 30% to 80%, delivering relief to millions of Americans crushed by skyrocketing costs. Announced via Truth Social on Sunday, this move signals Trump’s unrelenting commitment to putting American families first and dismantling the corrupt systems that have bled them dry for decades.
“For many years the World has wondered why Prescription Drugs and Pharmaceuticals in the United States States of America were SO MUCH HIGHER IN PRICE THAN THEY WERE IN ANY OTHER NATION, SOMETIMES BEING FIVE TO TEN TIMES MORE EXPENSIVE THAN THE SAME DRUG, MANUFACTURED IN THE EXACT SAME LABORATORY OR PLANT, BY THE SAME COMPANY???” Trump wrote. His frustration echoes the anger of everyday Americans who’ve watched Big Pharma rake in billions while they struggle to afford life-saving medications. The president’s words cut through the fog of excuses peddled by drug companies for too long.
The pharmaceutical giants have long justified their price gouging by pointing to research and development costs, claiming Americans alone must bear the burden. Trump isn’t buying it. “The Pharmaceutical/Drug Companies would say, for years, that it was Research and Development Costs, and that all of these costs were, and would be, for no reason whatsoever, borne by the ‘suckers’ of America, ALONE. Campaign Contributions can do wonders, but not with me, and not with the Republican Party,” he declared. This is a direct shot at the lobbyists and political insiders who’ve shielded Big Pharma’s profiteering at the expense of the American people.
Trump’s executive order is poised to be a game-changer. “We are going to do the right thing, something that the Democrats have fought for many years,” he stated. Signed this morning in the White House, this order will deliver immediate price cuts, reshaping the healthcare landscape. For too long, Americans have been overcharged for drugs that cost pennies elsewhere. Trump’s action aims to end this injustice and restore fairness to a system rigged against the working class.
The president’s plan hinges on the “Most Favored Nation” policy. “I will be instituting a MOST FAVORED NATION’S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World,” Trump said. This ensures Americans are no longer forced to subsidize the rest of the globe while paying exorbitant prices at home. The policy could save the U.S. trillions, redirecting those dollars back to families, small businesses, and communities.
President Trump is signing a historic Executive Order to significantly reduce drug prices for Americans.
This EO will help bypass costly middlemen and bring the prices Americans pay for prescription drugs in line with those paid by other nations.
Other Presidents merely talked… pic.twitter.com/KTD37JonpH
— Karoline Leavitt (@PressSec) May 12, 2025
This isn’t Trump’s first strike against Big Pharma. Last month, he signed an executive order standardizing Medicare payments for prescription drugs, including critical cancer treatments, regardless of where patients receive care. The White House estimated this could lower patient costs by up to 60%. By aligning Medicare payments with hospital acquisition prices—up to 35% less than what the government currently pays—the order delivers tangible savings to seniors and taxpayers.
Insulin, a lifeline for millions, is also in Trump’s crosshairs. The order targets low-income and uninsured patients, slashing insulin prices to as low as 3 cents and injectable epinephrine for allergic reactions to just $15, plus a small administrative fee. These cuts tackle the outrageous markups that have forced families to ration medications or go bankrupt to survive. Trump’s focus on affordability shows his administration’s resolve to protect the most vulnerable.
States, too, will feel the impact. The executive order facilitates drug importation programs, potentially saving millions in prescription costs. It also strengthens state-level deals on sickle-cell medications through Medicaid, empowering governors to fight back against pharmaceutical greed. These measures give states the tools to prioritize their citizens over corporate profits, aligning with the populist push for local control and accountability.
The Department of Health and Human Services, now led by Robert F. Kennedy Jr., is tasked with reviewing the Medicare Drug Price Negotiation Program, a Biden-era policy allowing Medicare to negotiate directly with drug companies. Trump’s team will scrutinize this program to ensure it serves Americans, not bureaucrats or corporate cronies. Kennedy’s outsider perspective makes him a fitting choice to challenge the entrenched interests in Washington.
Drug prices have spiraled out of control in recent years. Between January 2022 and January 2023, prescription costs surged over 15%, averaging $590 per drug product, with 46% of those increases outpacing inflation. Families are being squeezed, and Trump’s order is a direct response to their pain. His administration is exposing the pharmaceutical industry’s unchecked power and demanding accountability.
Trump’s first term laid the groundwork for these reforms. His administration capped Medicaid insulin prices at $35, a lifeline for diabetics crushed by rising costs. Now, he’s doubling down, expanding those efforts to cover more drugs and more Americans. This is a president who listens to the forgotten men and women, not the elite insiders who’ve profited off their suffering.
While global drug prices may rise as a result, Trump is unapologetic. “For the first time in many years, it will bring FAIRNESS TO AMERICA!” he proclaimed. His order is a declaration that the U.S. will no longer be the world’s piggy bank for Big Pharma. Americans deserve the same prices as other nations, and Trump is making it happen.
What do you think about this executive order? Has the pharma industry been taking advantage of Americans? Let us know your thoughts in the comments section below.